Pharmacyclics, Inc. (PCYC) Tops Q1 EPS by 39c

Pharmacyclics, Inc. (NASDAQ: PCYC) reported Q1 EPS of $1.14, $0.39 better than the analyst estimate of $0.75. Revenue for the quarter came in at $102.7 million versus the consensus estimate of $87.64 million.

For earnings history and earnings-related data on Pharmacyclics, Inc. (PCYC) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• MeiraGTx Holdings plc (MGTX) Tops Q2 EPS by 202c
• UBS Reiterates Buy Rating on Sysco (SYY) Following Trip to Company Headquarters